If you need more lookups,
subscriptions start at $34 USD/month.
Stu Dorman Location
California, United States
Stu Dorman Work
2024 -now Chief Commercial Officer (CCO) @
2020 -2024 Vice President, Oncology Business Unit Head @
2019 -2020 VP, Worldwide Commercialization - Opdivo and Yervoy @
2018 -2019 Head of US Hematology Marketing @
2016 -2018 Oncology Region Business Director @
2015 -2016 Worldwide General Manager, Hepatitis C Portfolio @
2014 -2015 Worldwide Marketing and Launch Lead, Hepatitis C Portfolio @
2014 -2014 Head of Operations, Worldwide Commercialization @
2014 -2014 Executive Director, Global Commercialization Strategy and Operations @
2012 -2014 Director and Portfolio Lead, Diabetes Payer Marketing and Access @
2010 -2012 Director, US Oncology Marketing (Sprycel) @
2008 -2010 Senior Product Manager, ERBITUX @
2008 -2008 Associate Director, US Oncology Commercial Strategy and Operations @
2006 -2008 Associate Director, Strategic Planning and Decision Analysis @
1999 -2004 Senior Consultant and Manager @
Stu Dorman Education
Stanford University
Master Of Business Administration
2004-2006
Harvard University
Bachelor Of Arts (Economics)
1995-1999
Green Vale School
Stu Dorman Skills
Oncology
Nephrology
Business Development
Product Development
Immunology
Marketing Strategy
Market Access
Biomarkers
Diabetes
Hospital Sales
Product Management
Strategy
Therapeutic Areas
Sales
Social Media Marketing
Customer Service
SQL
Leadership
Process Improvement
Stu Dorman Summary
Stu Dorman, based in California, United States, is currently a Chief Commercial Officer (CCO) at IDEAYA Biosciences. Stu Dorman brings experience from previous roles at Gilead Sciences and Bristol-Myers Squibb. Stu Dorman holds a 2004 - 2006 Master Of Business Administration @ Stanford University. With a robust skill set that includes Oncology, Nephrology, Business Development, Product Development, Immunology and more. Stu Dorman has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Stu Dorman?
Find contact details for 700 million professionals.